Comparison of two prognostic markers for malignant melanoma: MIA and S100 β

Tumor Biology

Volumn 22, Issue 1, 2001, Pages 54-58

  Juergensen, Andrea ^a   Holzapfel, Ute ^b   Hein, Rüdiger ^c   Stolz, Wilhelm ^a   Buettner, Reinhard ^b   Bosserhoff, Anja Katrin ^b  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b RWTH AACHEN UNIVERSITY   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Malignant melanoma; Melanoma inhibitory activity; S100 ; Tumor marker

Indexed keywords

CALCIUM BINDING PROTEIN; MELANOMA INHIBITORY PROTEIN; TUMOR MARKER; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CANCER STAGING; DIAGNOSTIC VALUE; DISEASE COURSE; DISEASE MARKER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; PRIORITY JOURNAL; PROGNOSIS;

EID: 0035230164     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1159/000030147     Document Type: Article

References (20)

1. Purification and analysis of growth regulating proteins secreted by a human melanoma cell line
2. Autocrine tumor cell growth-inhibiting activities from human malignant melanoma
3. Cloning of a novel malignant melanoma-derived growth-regulatory protein, MIA
4. Assignment of the human melanoma inhibitory activity gene (MIA) to 19q13.32-q13.33 by fluorescence in situ hybridization (FISH)
5. Cloning of a retinoic acid-sensitive mRNA expressed in cartilage and during chondrogenesis
6. Mouse CD-RAP/MIA gene: Structure, chromosomal localization, and expression in cartilage and chondrosarcoma
7. Structure and promoter analysis of the gene encoding the human melanoma-inhibiting protein MIA
8. Identification of melanoma inhibitory activity and other differentially expressed messenger RNAs in human melanoma cell lines with different metastatic capacity by messenger RNA differential display
9. Melanoma-inhibiting activity, a novel serum marker for progression of malignant melanoma
10. Clinical and prognostic relevance of serum S-100 beta protein in malignant melanoma
11. Serum S-100 protein: A potentially useful prognostic marker in cutaneous melanoma
12. The luminescence immunoassay S-100: A sensitive test to measure circulating S-100B: Its prognostic value in malignant melanoma
13. Elevated serum levels of S100 and survival in metastatic malignant melanoma
14. Lack of effect of particle size on the identification of the sentinel node in cutaneous malignancies
15. Prognostic significance of serum S100B detection compared with routine blood parameters in advanced metastatic melanoma patients
16. S100B protein detection in serum is a significant prognostic factor in metastatic melanoma
17. Measurements of tumor thickness
18. MIA (melanoma inhibitory activity): A potential serum marker for rheumatoid arthritis
19. Enzyme immunoassay for measurement of a subunit of S100 protein in human biological fluids
20. Melanoma-inhibitory activity protein, a useful marker to monitor melanoma patients treated with immunotherapy